Central fat accumulation is a strong risk factor for type 2 diabetes. Genome-wide association studies have identified numerous loci associated with body fat distribution. The objectives of the current study are to examine whether genes in genetic loci linked to fat distribution can be linked to fat cell size and number (morphology) and/or adipose tissue function. We show, in a cohort of 114 women, that almost half of the 96 genes in these loci are indeed associated with abdominal subcutaneous adipose tissue parameters. Thus, adipose mRNA expression of the genes is strongly related to adipose morphology, catecholamine-induced lipid mobilization (lipolysis), or insulin-stimulated lipid synthesis in adipocytes (lipogenesis). In conclusion, the genetic influence on body fat distribution could be mediated via several specific alterations in adipose tissue morphology and function, which in turn may influence the development of type 2 diabetes.
Adipose tissue is distributed in many different body regions. Central body fat accumulation is governed by genetic factors (1) and is, independently of total adiposity, associated with metabolic conditions such as type 2 diabetes and cardiovascular disease (2) . A recent genome-wide association (GWA) meta-analysis identified 68 genetic loci that associate with body fat distribution, primarily waist-to-hip ratio (WHR) but also related traits such as waist circumference (3) . Bioinformatics analysis of the genes in the vicinity of the 68 genetic loci implicated adipose pathways in the regulation of fat distribution, and several of the candidate genes are indeed expressed at the mRNA level in adipose tissue. However, direct evidence for these loci and/or genes being involved in adipocyte function is lacking in most cases.
Fat mass is determined by adipose tissue morphology (i.e., size and number of adipocytes) (4), and both parameters contribute to the total weight of specific human fat depots, thereby regulating fat distribution (5) . In addition, alterations in adipocyte function can also influence adipose distribution. The lipid droplet constitutes .95% of the fat cell volume. As reviewed (6) , impaired ability of the major lipolysis-regulating hormones, catecholamines, to stimulate the hydrolysis of adipocyte lipids (lipolysis) may cause retention of lipids in fat cells and thereby contribute to fat mass expansion. Insulin is a major anabolic hormone and controls lipid accumulation in fat cells. The ability of insulin to stimulate fat synthesis through glucose conversion into lipids (lipogenesis) could therefore also be of importance. Here, we investigated whether these adipocyte phenotypes (adipose morphology, lipolysis, and lipogenesis) could be linked to abdominal subcutaneous white adipose tissue (WAT) expression of 96 candidate genes in the vicinity of the recently described genetic loci for body fat distribution (3). This centrally located adipose region contributes to variations in WHR and in other parameters of body fat distribution.
RESEARCH DESIGN AND METHODS
The study included 114 Swedish women without diabetes who were recruited from the general adult population in the Stockholm (Sweden) area (Table 1) . They displayed a large interindividual variation in BMI and WHR. The study was approved by the regional ethics board, and written informed consent was obtained from each subject. They were investigated in the morning after an overnight fast, when abdominal subcutaneous WAT was obtained by fine-needle aspiration (7). WAT gene expression was assessed by Gene 1.0 or 1.1 ST Affymetrix arrays, as described (8) . Between-array results were normalized in Affymetrix Power Tools.
Adipocytes isolated from abdominal subcutaneous WAT were used to measure activation of lipolysis by isoprenaline (a synthetic catecholamine) and insulinstimulated lipogenesis, as described (9), and data distribution is summarized in Table 1 . By comparing the size of the adipocytes with the total amount of body fat, the morphology of WAT could be quantitatively determined (D values), as described in detail (10) . Negative D values indicate hyperplasia (many small adipocytes), and positive D values indicate hypertrophy (few but large adipocytes); the distribution of values is reported in Table 1 . Adipose hypertrophy is linked to insulin resistance and the development of type 2 diabetes, as discussed (10) .
Linear regression analysis showed age did not influence the examined parameters. As expected, an inverse relationship was found between BMI and insulin-stimulated lipogenesis (r = 0.27) or catecholamine-stimulated lipolysis (r = 0.28, P # 0.004 for both) but, in accordance with previous studies (10) , not with adipose morphology (r = 0.18, P = 0.13). Therefore, further analyses on lipolysis and lipogenesis were adjusted for BMI.
RESULTS
First, we analyzed all 22,168 probe sets on the arrays for association with WHR and the adipose phenotypes in R software using the SAM Bioconductor package (11) . Among significant genes, we focused on GWA candidates for body fat distribution; that is, all genes that were localized within 250 kb of the lead single nucleotide polymorphism in the loci associated with body fat distribution listed by Shungin et al. (3) in their Tables 1, 2 , and 3. This included all primary candidate genes in 49 genetic loci associated with WHR adjusted for BMI (WHRadjBMI) in the aforementioned GWA study (3) . We also included additional candidate genes that were obtained by expression quantitative trait loci (eQTL) analysis or given high priority according to bioinformatics analysis and all primary candidate genes in 19 loci associated with waist and hip circumference measures. Three genes were not represented with probes on the Affymetrix microarrays. The remaining 96 genes are listed in Supplementary Table 1 . The subset of genes whose expression was associated with WHR and with adipose phenotypes according to SAM analysis is shown in Supplementary Table 2 .
We next extended the analysis to take into account possible confounders. To this end, multiple regression analysis was used to investigate the associations between the expression of the 96 genes and WHR or the adipocyte phenotypes, taking into account the use of different array batches and, when appropriate, BMI. Because 96 genes were investigated, we considered a P value of , 0.0005 as statistically significant. There was a strong overlap between the results obtained by SAM and those obtained by multiple regression, although somewhat more genes were significant with SAM. We therefore focused on results obtained by regression analysis, which takes potential confounders into account.
As observed in Table 2 , only two genes-CALCRL and FAM13A-were correlated with WHR and WHRadjBMI, which is in accordance with previous WAT expression data on a few of the WHR-associated genes (12) . CALCRL and FAM13A were negatively associated with adipose morphology, whereas CPEB4, HLA-DRA, MSC, and PLCG2 correlated positively with this phenotype. Thus, WHR-associated genes may influence adipocyte size and number in abdominal subcutaneous WAT in opposite ways, resulting in different body fat distribution. Eight candidate genes for body fat distribution in Table 2 correlated with catecholamine-stimulated lipolysis, where all but one (CBX3) showed a positive association. None of these genes associated with adipose morphology, indicating that some genes linked to body fat distribution may influence central fat accumulation by specifically enhancing (in most cases) or suppressing the lipolytic activity of adipocytes. Fat cells were isolated from adipose tissue and incubated in vitro, exactly as described (8) , to determine lipolysis (glycerol release) and lipogenesis (incorporation of radiolabeled glucose into fat cell lipids). The cells were incubated in the absence or presence of increasing concentrations of isoprenaline (a synthetic catecholamine) or insulin, and the results at maximum effective concentrations were used. The isoprenaline effect was measured as the ratio of glycerol release without the drug. On a separate aliquot of isolated fat cells, their mean volume was measured and set in relation to the total body fat content, exactly as described in detail (10) , to obtain an adipose tissue morphology value. The measured volume was compared with the calculated expected volume given the subject's total fat mass. The difference between measured and calculated fat cell volume is the morphology value.
As demonstrated in Table 3 , a surprisingly large number of genes correlated with insulin-stimulated lipogenesis, 14 genes in a positive fashion and 21 in an inverse fashion. Apparently, regulation of insulininduced lipid synthesis (stimulation or inhibition) in adipocytes is a very important pathway in WAT that may link candidate genes to central fat distribution. Similar to lipolysis and morphology, the lipogenesis-associated genes seem specific for this adipocyte process because only 4 (CBX3, HLA-DRA, PLCG2, and PTPDC1) overlapped with the 15 genes associated with the other examined adipose phenotypes. These genes, linked to insulin function, may have a particular importance for the type 2 diabetes risk associated with central fat accumulation because insulin resistance is a key feature in this diabetic condition.
We used three batches of arrays to determine gene expression; however, results were similar within each of the batches. Combining the Gene 1.0 and 1.1 ST Affymetrix array results had a negligible effect on the findings. Data in Tables 2 and 3 were validated by realtime quantitative PCR (Supplementary Table 3 ) using RNA from subcutaneous WAT obtained from a previously examined cohort of 55 women (9) . We chose five genes displaying among the strongest correlations in the aforementioned tables and examined the relationship between WAT morphology, WHR, or insulin-stimulated lipogenesis and gene expression. Seven of the eight examined relationships showed a statistically significant relationship in agreement with the data presented in Tables 2 and 3 ; the eighth relationship was directionally consistent in the validation cohort.
To further explore the function of genetic variants associated with body fat distribution, we performed cis-eQTL analysis of the genes in Tables 2 and 3 . We related WAT expression of 32 genes to the genotype of 26 single nucleotide polymorphisms representing different genetic loci. We confirmed eQTLs for ZNF664 (rs4765219) and CMIP (rs2925979) and identified a new eQTL for PDXDC1 (rs4985155) (Supplementary Table 4 ) (3), three genes whose expression is associated with insulin-stimulated lipogenesis. The limited number of significant associations might be due to limited statistical power because only data from ;100 subjects were available for eQTL analysis.
We finally investigated the expression pattern of the genes in Tables 2 and 3 during differentiation of human subcutaneous progenitor cells to adipocytes (Table 4 ) using previously published gene expression array data (9) . There was no clear pattern for genes associated with lipolysis or lipogenesis (values not shown). However, five of the six morphology-linked genes in Table 1 showed a significant up-or downregulation during differentiation (CPEB4, PLCG2, HLA-DRA, FAM13A, and MSC). This indicates that some genes associated with body fat distribution may 
Multiple regression analysis was used with array batch and BMI (the latter only for lipolysis and WHR) as cofactors. For adipose morphology, negative standard coefficient values indicate a stimulatory effect of gene expression on hyperplasia and positive values indicate a stimulatory effect on hypertrophy. Lipolysis values were 10-log transformed. P # 0.0005 was considered to be statistically significant because 96 genes on the arrays were investigated in total. §Only expression data in adipose tissue reported in the literature. #Functional data in adipocytes/adipose tissue reported in the literature. □Also significantly correlated with WHRadjBMI, which is an adjustment described before (3).
influence WAT morphology via effects on adipose differentiation.
DISCUSSION
When data are taken together, 45 of 96 of the genes associated with genetic loci for body fat distribution show a relationship between WAT gene expression and different aspects of adipocyte function linked to subcutaneous abdominal fat accumulation. Most of these genes were associated with one specific adipocyte phenotype (morphology, lipolysis, or lipogenesis), which points to a very distinct role for each gene. Thus, our findings suggest a central role for adipocytes in linking genetic variants with central fat mass distribution. Admittedly, only a few genes showed correlation with WHR. One plausible explanation is that fat distribution is the far away clinical end point of multiple pathways partly differing between subjects (i.e., a multifactorial etiology involving heterogeneity between subjects). Specific genes can then show a stronger association with intermediate phenotypes than with the clinical outcome. It should also be clarified that the genetic association between WHR and the genetic loci studied here becomes strong when very large numbers of individuals are included. Because our present cohort included only 114 subjects, it is quite expected that the association with WHR becomes nonsignificant.
What is known about the role of the examined genes in fat cells? For each of the genes presented in Tables 2  and 3 , we searched for previous publications related to the topic on PubMed (http://www.ncbi.nlm.nih.gov/ pubmed). We used the key words "adipocyte," "fat cell," "adipose tissue," "lipolysis," and "lipogenesis." The genes 
